Solstein Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.5K Hold
67
0.01% 254
2026
Q1
$32.2K Hold
67
0.01% 257
2025
Q4
$37.6K Hold
67
0.02% 235
2025
Q3
$34.4K Hold
67
0.01% 231
2025
Q2
$21K Hold
67
0.01% 278
2025
Q1
$20.4K Hold
67
0.01% 198
2024
Q4
$22.3K Hold
67
0.01% 194
2024
Q3
$22.4K Hold
67
0.01% 197
2024
Q2
$27.6K Hold
67
0.02% 173
2024
Q1
$27.1K Hold
67
0.02% 173
2023
Q4
$20.5K Hold
67
0.02% 185
2023
Q3
$16.2K Hold
67
0.01% 194
2023
Q2
$16.1K Hold
67
0.01% 195
2023
Q1
$12.6K Hold
67
0.01% 191
2022
Q4
$14.2K Hold
67
0.01% 190
2022
Q3
$11K Hold
67
0.01% 222
2022
Q2
$10K Hold
67
0.01% 255
2022
Q1
$11K Hold
67
0.01% 287
2021
Q4
$15K Hold
67
0.01% 293
2021
Q3
$13K Hold
67
0.01% 331
2021
Q2
$12K Hold
67
0.01% 313
2021
Q1
$11K Buy
+67
New +$10.2K 0.02% 289

Other funds holding MEDP

Solstein Capital's MEDP Position: Q2 2026 in Review

Solstein Capital held its Medpace (MEDP) position steady in Q2 2026 at 67 shares worth $35.5K. The position accounts for 0.01% of the portfolio, ranked #254.

Solstein Capital first reported a position in MEDP in Q1 2021 and has held it in 22 quarters since. The position peaked at $37.6K in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Solstein Capital held 67 shares of Medpace worth $35.5K as of Q2 2026.
  • Solstein Capital left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.01% of Solstein Capital's portfolio in Q2 2026, its #254 holding.
  • Solstein Capital first reported a position in Medpace in Q1 2021 and has held it in 22 quarters since.
  • Solstein Capital's Medpace position peaked at $37.6K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.